A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain|Prognostic Stage IV Breast Cancer AJCC v8
Interventions: DRUG: Copanlisib|DRUG: Fulvestrant
Sponsor: National Cancer Institute (NCI)